retatrutide phase 2 trial new england journal of medicine (“reta”) is an experimental weight-loss drug currently in 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works In the REDEFINE 1 phase
Pay in 4 interest-free payments of $5.18 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26























